Physician profile
Michael R Komada
NPI 1093775009
$1,266.62
in general payments reported to CMS, 2019-2025
18 companies · $199 in 2025
The $199 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $116 · 2021: $51.72 · 2022: $49.73 · 2023: $233 · 2024: $319 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $751.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $597.89 | 2019-2025 | Watchman Flx, Watchman Access System, Avvigo Guidance System |
| Abbott Laboratories | $104.26 | 2020-2023 | Dragonfly Opstar |
| Shockwave Medical, INC | $100.90 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $89.20 | 2019 | |
| Pfizer INC. | $42.90 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $42.01 | 2019 | |
| Biosense Webster, INC. | $40.73 | 2025 | Carto 3 |
| Janssen Pharmaceuticals, INC | $37.43 | 2019 | |
| Welch Allyn | $32.18 | 2021 | |
| Medtronic, INC. | $26.59 | 2025 | Plasmablade(Tm) |
| Amgen INC. | $26.00 | 2019 | |
| Cardiva Medical, INC. | $25.81 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Philips North America LLC | $23.09 | 2024 | (Bq9) Coronary Ivus |
| Cardiovascular Systems INC. | $19.54 | 2021 | |
| Sanofi-Aventis U.S. LLC | $15.73 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $15.59 | 2024 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $14.27 | 2022 | |
| Irhythm Technologies, INC. | $12.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Komada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.